Franziska Haderk
机构：Boehringer Ingelheim (Germany), Boehringer Ingelheim (Egypt), Boehringer Ingelheim (South Korea) · ORCID：0000-0001-9658-2778
发表论文 61 篇 · 总被引 3795 次 · h-index 15
代表论文
- Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer (2024 · Nature Communications · 被引 95)
- The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance (2023 · Nature Genetics · 被引 92)
- A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer (2024 · mAbs · 被引 3)
- BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings (2026 · Cancer Research Communications · 被引 2)
- Table 4 from BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings (2026)
- Table 5 from BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings (2026)